Pharmacological therapy for myocardial infarction in the elderly. An 8-year analysis;Terapêutica farmacológica do infarto do miocárdio em idosos. Análise de oito anos

Arquivos Brasileiros de Cardiologia

Volumn 78, Issue 4, 2002, Pages 364-373

  Makdisse, Márcia Regina Pinho ^a   Matsushita, Andrea De M ^a   Gonçalves Jr , Iran ^a   Miranda, Odete ^a   Gomes, Ana Cristina ^a   Cartocci, Monica M ^a   Covre, Silvia ^a   De Camargo Carvalho, Antonio Carlos ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Elderly; Myocardial infarction; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGITALIS; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; NIFEDIPINE; NITRATE; VERAPAMIL;

ACUTE HEART INFARCTION; AGED; ARTICLE; ELDERLY CARE; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; TREATMENT OUTCOME;

EID: 0036256912     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0066-782X2002000400003     Document Type: Article

References (50)

1. Evaluation of cardiovascular risk in the elderly: The Framingham Study
2. Prognosis after acute myocardial infarction: A multivariate analysis of mortality and survival
3. Trends in survival of hospitalized myocardial infarction patients between 1970 and 1985: The Minnesota Heart Survey
4. Hospital mortality in acute infarction in the era of reperfusion therapy: The MITI (Myocardial Infarction Triage and Intervention) Project
5. Population-wide mortality trends among patients hospitalized for acute myocardial infarction: The Ontario Experience 1981 to 1991
6. Acute myocardial infarction in hospitalized patients over age 70
7. Infarto do miocárdio na era trombolítica: Elevada mortalidade em pacientes idosos
8. Using admission characteristics to predict short-term mortality from myocardial infarction in elderly patients: Results form the Cooperative Cardiovascular Project
9. Acute myocardial infarction in the Medicare population: Process of care and clinical outcomes
10. Temporal changes in the care and outcomes of elderly patients with acute myocardial infarction, 1987 through 1990
11. Effect of age on the response of the left ventricular ejection fraction to exercise
12. Acute myocardial infarction in the aged: Prognosis and management
13. Factors leading to shorter survival after acute myocardial infarction in patients aged 65 to 75 years compared with younger patients
14. Age and the cardiovascular system
15. Adherence to national guidelines for treatment of suspected acute myocardial infarction: Evidence for undertreatment in women and the elderly
16. Impact of clinical trials on the use of beta blockers after acute myocardial infarction and its relation to other risk indicators for death and 1-year mortality rate
17. Treatment with beta-adrenergic blocking agents after myocardial infarction: From randomized trials to clinical practice
18. Beta-blocker therapy in acute myocardial infarction: Evidence for underutilization in the elderly
19. Recent age-related trends in the use of thrombolytic therapy in patients who have had acute myocardial infarction
20. Aspirin for secondary prevention after acute myocardial infarction in the elderly: Prescribed use and outcomes
21. Comparison of clinical presentation of acute myocardial infarction in patients older than 65 years of age to younger patients: The Multicenter Chest Pain Study Experience
22. The exclusion of the elderly and women from clinical trials in acute myocardial infarction
23. Management and outcome of acute myocardial infarction in older patients in the thrombolytic era
24. Comparison of risk and patterns of practice in patients older and younger than 70 years with acute myocardial infarction in a two-year period (1987-1989)
25. Short and long term prognosis of acute myocardial infarction since introduction of thrombolysis
26. Recent age-related trends in the use of thrombolytic therapy in patients who have had acute myocardial infarction
27. Prognosis after first myocardial infarction: Comparison of Q-wave and non-Q-wave myocardial infarction in the Framingham Heart Study
28. Survie dans I'infarctus du myocarde au stade aigu dans un group de 369 patients admis consécutivement entre 1988 et 1992: Analyse des facters de risques et de la pratique médicale
29. II diretriz da sociedade brasileira de cardiologia para o tratamento do infarto agudo do miocárdio
30. The Göteborg Metoprolol Trial: Effect on mortality of metoprolol in acute myocardial infarction
31. A randomized trial of propranolol in patients with acute myocardial infarction: Mortality results
32. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction
33. A randomized placebo-controlled international trial
34. Randomized trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction
35. A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction
36. Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarcion
37. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the Survival And Ventricular Enlargment Trial
38. Age-related differences in the utilization of therapies post acute myocardial infarction
39. Trial of early nifedipine in acute myocardial infarction: The TRENT study
40. Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT): A randomized intervention trial of nifedipine in patients with acute myocardial infarction
41. Effect of verapamil on mortality and major events after acute myocardial infarction: The DAVIT (Danish Verapamil Infarction Trial) II
42. The effect ofdiltiazem on mortality and reinfarction after myocardial in farction
43. Evaluating effects of treatment in subgroups of patients within a clinical trial: The case of non-Q-wave myocardial infarction and beta-blockers
44. Effects of prophylactic lidocaine in suspected acute myocardial infarction: An overview of results from the randomized, controlled trials
45. Aspirin for secondary prevention after acute myocardial infarction in the elderly: Prescribed use and outcomes
46. Indications for fibrino-lytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1,000 patients
47. Recent age-related trends in the use of thrombolytic therapy in patients who have had acute myocardial infarction
48. Thrombolytic therapy in older patients